查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561566

2024-2032 年按治疗类别、配方、类型（处方止痛药、非处方止痛药）、配销通路和地区分類的局部止痛市场报告

Topical Pain Relief Market Report by Therapeutic Class, Formulation, Type (Prescription Pain Relief, Over the Counter Pain Relief), Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球局部止痛药市场规模达105IMARC Group美元。全球市场的主要驱动因素包括关节炎和肌肉骨骼疾病盛行率的上升、药物传输技术的不断进步、消费者对非侵入性和非药物治疗的偏好不断增加以及研发方面的大量投资。

局部止痛市场分析：

  • 市场成长与规模：在关节炎和肌肉骨骼疾病盛行率不断上升、药物传递技术的进步以及对非药物治疗的日益偏好等因素的推动下，市场正在经历强劲增长。市场规模庞大且持续扩大，各种产品满足处方药和非处方止痛需求。
  • 主要市场驱动力：关节炎和肌肉骨骼疾病发生率的上升，特别是随着全球人口老化，是推动止痛产品需求的主要驱动力。药物输送系统的技术进步提供了增强的功效和控制释放，对市场成长做出了重大贡献。
  • 技术进步：药物传输技术（包括微胶囊化和奈米製剂）的不断进步正在提高止痛产品的功效和效率。具有增强渗透性和更持久效果的创新配方正在满足消费者对有效、便利的疼痛管理解决方案的偏好。
  • 产业应用：止痛产品广泛应用于治疗关节炎、肌肉拉伤、扭伤和运动相关伤害等各种疾病。该市场既满足针对严重疼痛的处方治疗，也满足满足自我管理、轻度缓解疼痛需求的非处方药选择。
  • 主要市场趋势：
  • 消费者对非药物和非侵入性治疗的偏好日益增长是一个突出趋势，导致人们对止痛产品的接受度提高。产品范围的扩大包括天然和有机成分，符合整体和以健康为中心的医疗保健趋势。
  • 地理趋势：
  • 由于慢性疼痛的高盛行率、完善的医疗基础设施以及持续的研发计划，北美在市场上处于领先地位。由于人口众多、医疗保健意识不断提高以及可支配收入不断增加，亚太地区正在经历快速增长。
  • 竞争格局：
  • 市场主要参与者正在投资研发，以推出创新配方、增强药物输送系统并扩大其产品组合。伙伴关係、合作和收购是加强市场地位和利用互补能力的常见策略。
  • 挑战与机会：
  • 严格的监管框架，尤其是处方产品，为产品开发和市场进入带来了挑战。机会在于透过持续创新、利用线上分销管道以及开拓医疗保健需求未满足的新兴市场来满足消费者的多样化需求。

局部止痛市场趋势：

关节炎和肌肉骨骼疾病的盛行率不断增加

与口服药物相比，局部止痛产品（例如乳霜、凝胶和贴片）可提供针对性的疼痛缓解，且全身副作用的风险较低。这使得它们对于可能需要处理多种健康问题和药物的老年患者特别有吸引力。此外，人们越来越认识并接受局部疗法作为口服止痛药的可行替代品，进一步促进了市场的成长。患有骨关节炎和类风湿关节炎等疾病的患者经常发现局部应用可以立即缓解局部疼痛，从而提高他们的生活品质。具有增强渗透性和更持久效果的创新配方的发展也推动了消费者对这些产品的偏好。

药物传输技术的不断进步

该市场也受到药物输送技术不断进步的推动。创新的递送系统，包括微胶囊和奈米製剂，显着提高了止痛产品的功效和效率。这些技术能够更好地渗透皮肤、控制释放和靶向输送活性药物成分 (API)，从而改善疼痛管理效果。非侵入性给药方法的发展符合消费者对与传统口服药物相比副作用较少、全身暴露较低的治疗方法日益增长的偏好。增强的药物输送技术也为现有药物的重新配製提供了机会，有可能透过改善性能和患者依从性来重振旧 API。

增加研发投资（R&D）

製药公司加大研发投资进一步推动市场发展。这项投资旨在改进现有产品并开发功效更好、作用时间更长、副作用更少的新配方。研发工作也致力于探索具有镇痛特性的新型活性成分和天然化合物，以满足消费者对天然和有机产品日益增长的偏好。这些创新提高了产品的有效性，并有助于使产品在竞争激烈的市场中脱颖而出。产品组合的扩展包括一系列活性成分和不同的强度，以满足不同消费者的需求和偏好。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球局部止痛市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依治疗类别

  • 非阿片类药物
    • 市场趋势
    • 市场预测
  • 阿片类药物
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按配方

  • 奶油
    • 市场趋势
    • 市场预测
  • 凝胶
    • 市场趋势
    • 市场预测
  • 喷
    • 市场趋势
    • 市场预测
  • 修补
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按类型

  • 处方止痛药
    • 市场趋势
    • 市场预测
  • 非处方 (OTC) 止痛药
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 药局和药局
    • 市场趋势
    • 市场预测
  • 零售店
    • 市场趋势
    • 市场预测
  • 网上商店
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Advacare Pharma
    • Exzell Pharma Inc.
    • Glaxosmithkline Plc
    • Johnson & Johnson
    • Novartis AG
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Sanofi SA
    • Sun Pharmaceutical Industries Limited
    • Topical Biomedics Inc.
Product Code: SR112024A4441

The global topical pain relief market size reached US$ 10.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The global market is primarily driven by the rising prevalence of arthritis and musculoskeletal disorders, continual advancements in drug delivery technologies, increasing consumer preference for non-invasive and non-pharmacological treatments, and significant investment in research and development.

Topical Pain Relief Market Analysis:

  • Market Growth and Size: The market is experiencing robust growth, driven by factors such as the increasing prevalence of arthritis and musculoskeletal disorders, advancements in drug delivery technologies, and the growing preference for non-pharmacological treatments. The market size is substantial and continues to expand, with a diverse range of products catering to both prescription and over-the-counter pain relief needs.
  • Major Market Drivers: The rising incidence of arthritis and musculoskeletal conditions, particularly with an aging global population, is a major driver propelling the demand for pain relief products. Technological advancements in drug delivery systems, offering enhanced efficacy and controlled release, contribute significantly to market growth.
  • Technological Advancements: Ongoing advancements in drug delivery technologies, including microencapsulation and nano-formulations, are improving the efficacy and efficiency of pain relief products. Innovative formulations with enhanced penetration and longer-lasting effects are addressing consumer preferences for effective and convenient pain management solutions.
  • Industry Applications: Pain relief products find extensive applications in treating various conditions such as arthritis, muscle strains, sprains, and sports-related injuries. The market caters to both prescription-based treatments for severe pain conditions and over-the-counter options for self-manageable, milder pain relief needs.
  • Key Market Trends:
  • Growing consumer preference for non-pharmacological and non-invasive treatments is a prominent trend, leading to increased acceptance of pain relief products. The expansion of the product range to include natural and organic ingredients aligns with the trend towards holistic and wellness-focused healthcare.
  • Geographical Trends:
  • North America leads the market, driven by a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and ongoing research and development initiatives. Asia Pacific is witnessing rapid growth due to a large population, increasing healthcare awareness, and rising disposable incomes.
  • Competitive Landscape:
  • Key players in the market are investing in research and development to introduce innovative formulations, enhance drug delivery systems, and expand their product portfolios. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.
  • Challenges and Opportunities:
  • Stringent regulatory frameworks, especially for prescription-based products, pose challenges in product development and market entry. Opportunities lie in addressing the diverse needs of consumers through continuous innovation, leveraging online distribution channels, and tapping into emerging markets with unmet healthcare needs.

Topical Pain Relief Market Trends:

Increasing prevalence of arthritis and musculoskeletal disorders

Topical pain relief products, such as creams, gels, and patches, offer targeted pain relief with a lower risk of systemic side effects compared to oral medications. This makes them particularly appealing for elderly patients who may be managing multiple health issues and medications. Moreover, the increasing awareness and acceptance of topical therapies as a viable alternative to oral analgesics further contribute to the market growth. Patients with conditions, such as osteoarthritis and rheumatoid arthritis often find that topical applications provide immediate relief from localized pain, improving their quality of life. The development of innovative formulations with enhanced penetration and longer-lasting effects also drives consumer preference towards these products.

Continual advancements in drug delivery technologies

The market is also driven by continuous advancements in drug delivery technologies. Innovative delivery systems, including microencapsulation and nano-formulations have significantly enhanced the efficacy and efficiency of pain relief products. These technologies enable better skin penetration, controlled release, and targeted delivery of active pharmaceutical ingredients (APIs), leading to improved pain management outcomes. The development of non-invasive delivery methods aligns with the growing consumer preference for treatments with fewer side effects and lower systemic exposure compared to traditional oral medications. Enhanced drug delivery technologies also open up opportunities for the reformulation of existing drugs, potentially revitalizing older APIs with improved performance and patient compliance.

Increased investment in research and development (R&D)

The market is further propelled by increased investment in research and development by pharmaceutical companies. This investment is aimed at improving existing products and developing new formulations with better efficacy, longer duration of action, and fewer side effects. R&D efforts are also focused on exploring novel active ingredients and natural compounds with analgesic properties, catering to the growing consumer preference for natural and organic products. These innovations enhance product effectiveness and aid in differentiating products in a competitive market. The expansion of the product portfolio to include a range of active ingredients and varying strengths caters to diverse consumer needs and preferences.

Topical Pain Relief Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on therapeutic class, formulation, type, and distribution channel.

Breakup by Therapeutic Class:

  • Non-Opioids
  • Opioids

Non-opioids accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the therapeutic class. This includes non-opioids and opioids. According to the report, non-opioids represented the largest segment.

The non-opioids segment holds the largest share in the global market, driven by their widespread acceptance and lower risk profile compared to opioids. This segment includes products containing active ingredients such as NSAIDs capsaicin, lidocaine, and salicylates. Non-opioid topical analgesics are favored for their efficacy in treating mild to moderate pain, particularly in conditions, including arthritis, muscle strains, and sprains. Their popularity is further bolstered by the minimal risk of addiction and fewer systemic side effects, making them suitable for a broader range of patients, including the elderly and those with chronic conditions.

On the contrary, the opioids segment, although smaller compared to non-opioids, plays a crucial role in the market, particularly for patients with severe or chronic pain unresponsive to non-opioid treatments. Topical opioids typically include formulations with controlled concentrations of active substances, including morphine, fentanyl, and buprenorphine. The advantage of topical opioids lies in their ability to provide potent pain relief directly at the site of pain with reduced systemic exposure.

Breakup by Formulation:

  • Cream
  • Gel
  • Spray
  • Patch
  • Others

Patch holds the largest share in the industry

A detailed breakup and analysis of the market based on the formulation have also been provided in the report. This includes cream, gel, spray, patch, and others. According to the report, patch accounted for the largest market share.

The patch segment dominates the market segmentation based on formulation in the market. Patches offer a convenient and sustained-release delivery system for active pharmaceutical ingredients, ensuring prolonged and controlled pain relief. These patches are applied directly to the skin, providing localized treatment with minimal systemic absorption. The popularity of patches can be attributed to their ease of use and long-lasting effects, making them particularly appealing for patients seeking continuous pain management. The transdermal delivery method minimizes the need for frequent reapplication, enhancing patient compliance. Additionally, patches are available in various strengths, catering to a diverse range of pain intensities and conditions.

On the other hand, creams are well-received for their smooth texture and quick absorption, providing rapid relief to localized areas of pain. This formulation is favored for its ease of application and the ability to cover larger surface areas, making it suitable for conditions such as arthritis and muscle soreness. Creams often contain active ingredients, including NSAIDs, menthol, or camphor, addressing various types of pain.

Furthermore, the gel segment in the global market holds a significant share, driven by its suitability for targeted pain relief and versatility in application. Gels provide a cooling or warming sensation upon application, offering an additional layer of comfort for users. This formulation is popular for its quick absorption and ability to deliver active ingredients directly to the affected area. Gels are commonly used for conditions like arthritis, joint pain, and muscle strains.

Moreover, the spray segment is a dynamic and expanding category in the market, gaining traction for its convenient and precise application. Pain relief sprays are known for their quick and even distribution of active ingredients over the affected area, providing instant relief. This formulation is often preferred for its non-greasy nature and the ability to reach areas that may be challenging to treat with creams or patches.

Breakup by Type:

  • Prescription Pain Relief
  • Over the Counter (OTC) Pain Relief

The report has provided a detailed breakup and analysis of the market based on the type. This includes prescription pain relief and over the counter (OTC) pain relief.

Prescription pain relief formulations often contain potent active ingredients and may include opioids or higher concentrations of non-opioid analgesics. These products are typically recommended by healthcare practitioners after a thorough assessment of the patient's medical history and pain severity. The prescription segment adheres to strict regulatory controls and is subject to healthcare provider oversight to ensure appropriate use and minimize the risk of adverse effects. The demand for prescription pain relief is driven by patients with conditions such as post-surgical pain, neuropathic pain, or other complex pain syndromes that may not be effectively managed by over-the-counter alternatives.

On the contrary, over the counter (OTC) pain relief segment constitutes a substantial portion of the pain relief market, appealing to consumers seeking accessible and self-manageable solutions for mild to moderate pain. OTC products are available without the need for a prescription, allowing consumers to make independent choices for their pain management needs.

Breakup by Distribution Channel:

  • Pharmacy and Drug Stores
  • Retail Stores
  • Online Stores

Online stores exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes pharmacy and drug stores, retail stores, and online stores. According to the report, online stores accounted for the largest market share.

The online stores segment stands out as the largest in the market segmentation based on distribution channels for pain relief products. The rise of e-commerce has transformed the way consumers purchase healthcare products, including pain relief solutions. Online stores offer a vast array of choices, allowing consumers to explore different brands, formulations, and customer reviews before making a purchase decision. The convenience of doorstep delivery further enhances the appeal of online channels, particularly for individuals with mobility issues or those seeking a discreet shopping experience. The online segment benefits from the global reach, enabling consumers to access a diverse range of products that may not be available in local stores.

On the other hand, the retail stores segment is another significant distribution channel for pain relief products, encompassing a diverse range of general merchandise and convenience stores. Retail stores offer accessibility to a broad consumer base, making pain relief products readily available during routine shopping trips. These outlets typically stock a variety of over-the-counter pain relief options, appealing to consumers seeking convenience and a quick purchase experience.

Furthermore, the pharmacy and drug stores segment represent a significant portion of the market for pain relief products, offering a traditional and trusted distribution channel for consumers seeking immediate access to pain management solutions. These establishments provide a wide range of over the counter and prescription pain relief products, allowing customers to receive personalized recommendations from pharmacists.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest topical pain relief market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America stands out as the largest segment for pain relief products. The region's dominance is attributed to several factors, including a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and a strong emphasis on research and development. North America has a substantial aging population, contributing to an increased incidence of musculoskeletal disorders and arthritis, augmenting the demand for effective pain relief solutions. Additionally, the region's proactive approach to healthcare, coupled with a higher awareness of pain management options, supports the robust growth of the topical pain relief market.

On the other hand, the Asia Pacific region is a dynamic and rapidly growing segment in the market for pain relief products. Factors such as a large population, increasing healthcare awareness, and rising disposable incomes contribute to the expanding market in this region. As lifestyles become more sedentary and the aging population grows, there is a rise in the prevalence of chronic conditions, fueling the demand for effective pain management solutions. Moreover, the cultural acceptance of topical therapies, along with the availability of a diverse range of traditional remedies, adds to the market's versatility.

Additionally, Europe represents a significant market segment for pain relief products, characterized by a mature healthcare system, a high prevalence of chronic conditions, and a strong emphasis on wellness. The region's aging population contributes to the demand for pain management solutions, particularly for conditions, including osteoarthritis and rheumatoid arthritis. European consumers are increasingly inclined towards non-pharmacological and non-invasive pain relief options, aligning with the global trend.

Moreover, Latin America emerges as a significant and growing market segment for pain relief products, driven by factors such as a rising middle class, increasing healthcare awareness, and a growing aging population. The region experiences a considerable burden of musculoskeletal disorders and sports-related injuries, propelling the demand for effective pain relief solutions.

Furthermore, the Middle East and Africa represent a developing market segment for pain relief products. The region's market is influenced by factors such as a growing population, improving healthcare infrastructure, and an increasing awareness of pain management options. Chronic conditions, including musculoskeletal disorders, are on the rise, contributing to the demand for pain relief solutions.

Leading Key Players in the Topical Pain Relief Industry:

Key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. This includes investments in research and development to introduce innovative formulations, enhanced drug delivery systems, and novel active ingredients. Companies are focusing on expanding their product portfolios to address a wide range of pain conditions and consumer preferences. Additionally, marketing efforts emphasize the efficacy and safety of their products, targeting both healthcare professionals and informed consumers. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Advacare Pharma
  • Exzell Pharma Inc.
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Topical Biomedics Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • 31 August 2023: Johnson & Johnson launched new pain solution, the topical Tylenol(R) Precise(TM) Pain Relieving Cream. Tylenol Precise fits active lifestyles with a rapid-absorbing formula, fragrance-free and fresh scent options for discreet use, and a uniquely designed rollerball for hands-free, no-mess application leaving skin clear of sticky residues.
  • 23 June 2023: Exzell Pharma Inc., the brand house of Myoflex, announced a multiyear partnership with Pickleball Canada, the National Sport Organization for pickleball. Myoflex has been used by active people of all ages and abilities for muscle aches, strains, and pains.
  • 24 February 2021: Reckitt Benckiser Group Plc announced that it has entered into a definitive agreement to acquire the Biofreeze brand from Performance Health. The acquisition represents a unique and exciting opportunity to unlock value through RB's expertise, global operating footprint, and infrastructure. Biofreeze is a perfect fit with RB's Health platform and deepens RB's presence within the broader pain category.

Key Questions Answered in This Report:

  • How has the global topical pain relief market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global topical pain relief market?
  • What is the impact of each driver, restraint, and opportunity on the global topical pain relief market?
  • What are the key regional markets?
  • Which countries represent the most attractive topical pain relief market?
  • What is the breakup of the market based on the therapeutic class?
  • Which is the most attractive therapeutic class in the topical pain relief market?
  • What is the breakup of the market based on the formulation?
  • Which is the most attractive formulation in the topical pain relief market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the topical pain relief market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the topical pain relief market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global topical pain relief market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Topical Pain Relief Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutic Class

  • 6.1 Non-Opioids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Opioids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Formulation

  • 7.1 Cream
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Patch
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Type

  • 8.1 Prescription Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Over the Counter (OTC) Pain Relief
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Pharmacy and Drug Stores
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Advacare Pharma
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Exzell Pharma Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Glaxosmithkline Plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Novartis AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Pfizer Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Reckitt Benckiser Group Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi S.A.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Sun Pharmaceutical Industries Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Topical Biomedics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Topical Pain Relief Market: Major Drivers and Challenges
  • Figure 2: Global: Topical Pain Relief Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Topical Pain Relief Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Topical Pain Relief Market: Breakup by Therapeutic Class (in %), 2023
  • Figure 5: Global: Topical Pain Relief Market: Breakup by Formulation (in %), 2023
  • Figure 6: Global: Topical Pain Relief Market: Breakup by Type (in %), 2023
  • Figure 7: Global: Topical Pain Relief Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Topical Pain Relief Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Topical Pain Relief (Non-Opioids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Topical Pain Relief (Non-Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Topical Pain Relief (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Topical Pain Relief (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Topical Pain Relief (Cream) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Topical Pain Relief (Cream) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Topical Pain Relief (Gel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Topical Pain Relief (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Topical Pain Relief (Spray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Topical Pain Relief (Spray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Topical Pain Relief (Patch) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Topical Pain Relief (Patch) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Topical Pain Relief (Other Formulations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Topical Pain Relief (Other Formulations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Topical Pain Relief (Prescription Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Topical Pain Relief (Prescription Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Topical Pain Relief (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Topical Pain Relief (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Topical Pain Relief (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Topical Pain Relief (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Topical Pain Relief Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Topical Pain Relief Industry: SWOT Analysis
  • Figure 83: Global: Topical Pain Relief Industry: Value Chain Analysis
  • Figure 84: Global: Topical Pain Relief Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Topical Pain Relief Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
  • Table 3: Global: Topical Pain Relief Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
  • Table 4: Global: Topical Pain Relief Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 5: Global: Topical Pain Relief Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Topical Pain Relief Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Topical Pain Relief Market: Competitive Structure
  • Table 8: Global: Topical Pain Relief Market: Key Players